The INVOLVE IrbesartaN in the eValuation of the OutLook of high risk cardioVascular patiEnts brand, founded in 2006 (France), from 2757 sister brands and 17478 competing brands. The INVOLVE IrbesartaN in the eValuation of the OutLook of high risk cardioVascular patiEnts brand is owned by SANOFI, a company listed in Paris. Its International Securities Identification Number (ISIN) is FR0000120578. INVOLVE IrbesartaN in the eValuation of the OutLook of high risk cardioVascular patiEnts is part of the Drug Manufacturers activity sector.

INVOLVE IrbesartaN in the eValuation of the OutLook of high risk cardioVascular patiEnts is a brand of SANOFI (SAN) Sustainability

International deposit : 2006 Business sector Drug Manufacturers
Here is the evolution of interest in SANOFI "sustainability" criteria around the world over the past five years. The graph shows the evolution of the search rate over time, where the value 100 indicates the week with the most searches.
What is the brand's web response on its sustainability
Result of Google's query: "INVOLVE IrbesartaN in the eValuation of the OutLook of high risk cardioVascular patiEnts sustainability"
Sustainability -> Share price